Literature DB >> 2423139

Synergistic stimulation of histamine release from rat peritoneal mast cells by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters.

K Ohuchi, N Hirasawa, C Takahashi, M Watanabe, S Tsurufuji, H Fujiki, M Suganuma, H Hakii, T Sugimura, S B Christensen.   

Abstract

Thapsigargin, a non-TPA (12-O-tetradecanoylphorbol 13-acetate)-type tumor promoter, provoked histamine release from rat peritoneal mast cells at concentrations above 30 ng/ml, but not at 10 ng/ml. TPA-type tumor promoters such as TPA, teleocidin and aplysiatoxin released very little, if any, histamine even at 100 ng/ml. When mast cells were incubated in medium containing thapsigargin at 10 ng/ml and varying concentrations of TPA-type tumor promoters, histamine release was increased synergistically. Maximum synergistic effects were observed at 10 ng/ml of each TPA-type tumor promoter. Palytoxin, another non-TPA-type tumor promoter, having no effect on histamine release at up to 10 pg/ml, also induced histamine release in the presence of 10 ng/ml of each TPA-type tumor promoter. However, no synergistic effect on histamine release was observed when mast cells were incubated in medium containing two different non-TPA-type tumor promoters, e.g., 10 ng/ml thapsigargin and 10 pg/ml palytoxin, or in medium containing two different TPA-type tumor promoters, e.g., TPA and teleocidin, TPA and aplysiatoxin, or teleocidin and aplysiatoxin (all at 10 ng/ml). These results suggest that the release of histamine from mast cells is stimulated synergistically under the mutual influence of TPA-type tumor promoters and non-TPA-type tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423139     DOI: 10.1016/0167-4889(86)90127-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non-(12-O-tetradecanoylphorbol-13-acetate) (TPA)-type tumor promoter.

Authors:  K Ohuchi; T Sugawara; M Watanabe; N Hirasawa; S Tsurufuji; H Fujiki; T Sugimura; S B Christensen
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.

Authors:  M Watanabe; M Yamada; S Mue; K Ohuchi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

3.  Modulation of phospholipase A2 activity by the tumour promoters phorbol esters and teleocidin.

Authors:  K Y Nam; A Morino; S Kimura; H Fujiki; Y Imanishi
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

4.  Analysis of the stimulative effect of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages.

Authors:  K Ohuchi; T Sugawara; M Watanabe; N Hirasawa; S Tsurufuji; H Fujiki; S B Christensen; T Sugimura
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.